High Blood Pressure (HBP) is a major risk factor for cardiovascular disease and related mortality, with recent estimates that show that 46% (or 116 million) of US adults have HBP.
Despite strong guideline-based recommendations for the accurate diagnosis and effective treatment of HBP, existing quality measures for BP control have not changed over the past several years, and now may be worsening during the COVID-19 pandemic.
Internationally recognized experts will discuss urgent imperatives for a new, cross-cutting “Blueprint for Change”, calling on leaders of health systems, payers, public health and technology companies to work collaboratively to measurably improve Guideline-based through a new system of care delivery for the many Americans with HBP.
Co-sponsored with: AJMQ and ACMQ
Recommended CitationCarey, MD, Robert; Casey, MD, MPH, MBA, FACP, FAHA, DFAAPL, DFACMQ, Don; Commodore-Mensah, PhD, MHS, RN, Yvonne; and Smith, MPH, BA, BSN, RN, Alison P., "Controlling High Blood Pressure: An Evidence-Based Blueprint for Change" (2021). Population Health Leadership Series: PopTalk Webinars. Paper 29.